['TABLE 5 EFFECTS ON STEADY-STATE FEXOFENADINE PHARMACOKINETICS AFTER 7 DAYS OF CO-ADMINISTRATION WITH FEXOFENADINE HYDROCHLORIDE 120 MG EVERY 12 HOURS IN HEALTHY ADULT SUBJECTS (N=24)', 'CONCOMITANT DRUG', 'CMAXSS (PEAK PLASMA CONCENTRATION)', 'AUCSS(0-12H) (EXTENT OF SYSTEMIC EXPOSURE)', 'ERYTHROMYCIN (500 MG EVERY 8 HRS)', '+82%', '+109%', 'KETOCONAZOLE (400 MG ONCE DAILY)', '+135%', '+164%']